Andreas Maetzel, Senior Vice President, Medical at KalVista Pharmaceuticals, Inc. (KALV), sold 139,933 shares at $25.79 ($3.5M) on 2021-04-27, disclosed to the SEC on 2021-04-29.
Open-market sale of $3.5M KALV by Senior Vice President, Medical. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.79 | 11,017 | $284K | 8.0% |
| 2 | $25.79 | 11,017 | $284K | 8.0% |
| 3 | $25.25 | 15,000 | $379K | 10.7% |
| 4 | $25.50 | 10,620 | $271K | 7.7% |
| 5 | $25.54 | 10,000 | $255K | 7.2% |
| 6 | $25.65 | 507 |
| $13K |
| 0.4% |
| 7 | $25.04 | 40,886 | $1.0M | 29.0% |
| 8 | $25.04 | 40,886 | $1.0M | 29.0% |
| Total | $25.25 avg | 139,933 | $3.5M | 100% |